Department of General Medicine, Saga Medical School, 5-1-1 Nabeshima, Saga, 849-8501, Japan.
J Gastroenterol. 2011 Jan;46 Suppl 1:70-8. doi: 10.1007/s00535-010-0340-3. Epub 2010 Nov 2.
Our previous studies have indicated a close association between visceral fat accumulation and hepatic steatosis in nonalcoholic fatty liver disease (NAFLD). This study investigated whether visceral fat accumulation was related to the pathogenesis and disease progression of nonalcoholic steatohepatitis (NASH)/NAFLD.
First, a total of 550 subjects who underwent a health checkup and measurement of visceral fat accumulation, done with a bioelectrical impedance analyzer (X-SCAN; Owa Medical, Fukuoka, Japan), were included. The relationship between visceral fat accumulation and biochemical parameters was examined. Second, a total of 74 patients with NASH/NAFLD who underwent liver biopsy were reviewed. Visceral fat accumulation was determined by abdominal computed tomography. The association between visceral fat accumulation and the histopathological grade/stage determined by the NAFLD activity score and Brunt's classification was evaluated.
There was a significant relationship between visceral fat accumulation and glucose, triglyceride, and alanine aminotransferase (ALT; r = 0.423, P < 0.01). In stepwise regression analysis, visceral fat area (VFA), serum triglyceride level, and serum low-density lipoprotein (LDL)-cholesterol level were selected as predictor variables for serum ALT level, in a continuous manner (serum ALT level = -1.359 + 0.143 × VFA + 0.046 × triglyceride + 0.059 × LDL, R(2) = 0.217, P < 0.001). In patients with NASH, there was no correlation between histological grade and the visceral fat volume. Visceral fat accumulation in patients with stage 3/4 advanced NASH was greater than that in patients with stage 1/2 early NASH (P < 0.05).
These results suggest that visceral fat accumulation plays a role in steatosis and fibrosis in the pathogenesis and prognosis of NAFLD.
我们之前的研究表明,非酒精性脂肪肝(NAFLD)患者内脏脂肪堆积与肝脂肪变性密切相关。本研究旨在探讨内脏脂肪堆积与非酒精性脂肪性肝炎(NASH)/NAFLD 的发病机制和疾病进展的关系。
首先,共纳入 550 例在健康体检中接受内脏脂肪堆积测量的受试者,使用生物电阻抗分析仪(X-SCAN;日本福冈 Owa Medical)进行测量。分析了内脏脂肪堆积与生化参数之间的关系。其次,回顾性分析了 74 例经肝活检诊断为 NASH/NAFLD 的患者。通过腹部计算机断层扫描(CT)确定内脏脂肪堆积。评估了内脏脂肪堆积与通过非酒精性脂肪性肝病活动度评分(NAFLD-activity score)和 Brunt 分类确定的组织病理学分级/分期之间的关系。
内脏脂肪堆积与血糖、甘油三酯和丙氨酸氨基转移酶(ALT;r = 0.423,P < 0.01)显著相关。在逐步回归分析中,内脏脂肪面积(VFA)、血清甘油三酯水平和血清低密度脂蛋白(LDL)-胆固醇水平被选为血清 ALT 水平的预测变量,呈连续方式(血清 ALT 水平=-1.359+0.143×VFA+0.046×甘油三酯+0.059×LDL,R²=0.217,P < 0.001)。在 NASH 患者中,组织学分级与内脏脂肪体积之间无相关性。3/4 期进展期 NASH 患者的内脏脂肪堆积量大于 1/2 期早期 NASH 患者(P < 0.05)。
这些结果表明,内脏脂肪堆积在 NAFLD 的发病机制和预后中与脂肪变性和纤维化有关。